The cyclooxygenase-2 inhibitors: safety and effectiveness. - Wikidata - awgldk - TriplyDB

The cyclooxygenase-2 inhibitors: safety and effectiveness.

The cyclooxygenase-2 inhibitors: safety and effectiveness.

http://www.wikidata.org/entity/Q33735395

about

Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder.Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.Meloxicam and selective COX-2 inhibitors in the management of pain in the palliative care population.Adverse Drug Events Involving COX-2 Inhibitors.Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials Safe drug prescribing Direct superoxide scavenging activity of nonsteroidal anti-inflammatory drugs: determination by electron spin resonance using the spin trap method.Cyclooxygenase inhibitor blocks rebound response after NO inhalation in an endotoxin model.Rofecoxib administration to paediatric patients undergoing adenotonsillectomy.Tacrolimus and nonsteroidal anti-inflammatory drugs: an association to be avoided.The effect of mixed-solvent and terpenes on percutaneous absorption of meloxicam gel.

P2860

Q33843521-62C05A9B-586E-497E-9EB3-E829D33AC15C Q35195182-CF9CD229-A8D7-48EF-93B8-01D0F7889D3E Q35196870-D8ED5813-DE8A-4B0A-8A16-5B1BB3B4D882 Q35201026-11F03069-5C9D-4B5B-AD31-406372BF6773 Q35825968-4F4C275A-16FC-49DA-9993-078D6C4F2394 Q38838396-35DA8596-B9E4-450F-89C9-849052E6343F Q42759925-75B80484-B6D8-4078-8BE8-1EFFC102B5B4 Q43544049-C23330AB-FF3E-4C2A-96D2-C174E40F11BC Q44251636-8D822C4B-3DC8-43B1-A9CE-ED87AFF7FDF0 Q44939290-80A8E478-AC48-40B0-8F2B-2C003CD003F2 Q46565086-5DE9F69A-2A71-4155-9419-5A4CC43DB226 Q46984706-3B071C1A-538F-4122-B170-F221C91B55BC

P2860

The cyclooxygenase-2 inhibitors: safety and effectiveness.

http://www.wikidata.org/entity/Q33735395

description

1999 nî lūn-bûn

@nan

1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

The cyclooxygenase-2 inhibitors: safety and effectiveness.

@ast

The cyclooxygenase-2 inhibitors: safety and effectiveness.

@en

type

label

The cyclooxygenase-2 inhibitors: safety and effectiveness.

@ast

The cyclooxygenase-2 inhibitors: safety and effectiveness.

@en

prefLabel

The cyclooxygenase-2 inhibitors: safety and effectiveness.

@ast

The cyclooxygenase-2 inhibitors: safety and effectiveness.

@en

P1433

Q33735395-9D3B2ED0-BD4D-4666-9998-0CA13C432151

P1476

Q33735395-A14AF8A8-4A42-4720-BB26-C991B60DFFE0

P2093

Q33735395-9C6FA3D2-9E3B-4918-B3D5-97A66DD7B705

Q33735395-E422473C-CD60-4505-ADFD-2EE69F1ADC48

P2860

Q33735395-0581228C-08B4-4C81-8DDF-64E9860A1EFA

Q33735395-16D160B7-F20E-40C2-9EB5-0BEBA4D95AC7

Q33735395-25A2D7E7-8E2D-4E1D-A4EB-4B21B6CDF447

Q33735395-4617AF8E-B0C1-4283-8296-5A7AA79CE870

Q33735395-5D642352-581D-4748-8A38-2D124057C9D2

Q33735395-7A135066-08BE-483C-9675-2CE7E471A10B

Q33735395-88B6220F-6596-45CD-8DA4-B1496662597D

Q33735395-8A070FC3-A43E-410B-AB05-8DC3DDB3F50C

Q33735395-8FCE4A25-3230-4E6C-942B-31C66318C5F6

Q33735395-9CE94C3E-5E48-42E7-8863-4F0BD0EA8513

P304

Q33735395-32D1305C-06D5-41A6-93FB-03E0A7B08EF2

P31

Q33735395-898A4E1D-0999-4395-B56D-F479CD8D2BB4

P356

Q33735395-EDF7C041-6828-4150-85E6-3799AF26F172

P407

Q33735395-260DCB65-44D9-4079-B486-AC0A25AD5A6C

P433

Q33735395-FA825E73-BBE4-4AB5-89A1-963DB0A33E53

P478

Q33735395-A780C717-0AB8-431D-AA73-9F1F44E143E3

P577

Q33735395-BAEF35A6-3A35-4C64-AE00-12058BE981D3

P5875

Q33735395-78BB3DDF-39EE-443D-ADFE-EB69B7D86632

P698

Q33735395-F8737CEC-1C0A-41D6-A662-39DA9F1E4C83

P356

P1433

Annals of Pharmacotherapy

P1476

The cyclooxygenase-2 inhibitors: safety and effectiveness.

@en

P2093

B Kaplan-Machlis

http://www.w3.org/2001/XMLSchema#string

B S Klostermeyer

http://www.w3.org/2001/XMLSchema#string

P2860

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients with acute sciatica.

Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthriti

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.

A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis.

A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.

Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium.

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.

P304

979-988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.18415

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

1999-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12806739

http://www.w3.org/2001/XMLSchema#string

P698

10492503

http://www.w3.org/2001/XMLSchema#string